Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/444
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nikhil Suresh | - |
dc.contributor.author | Dr. Asif E. (Guided by) | - |
dc.date.accessioned | 2021-12-16T11:52:27Z | - |
dc.date.available | 2021-12-16T11:52:27Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/444 | - |
dc.publisher | The National University of Advanced Legal Studies | en_US |
dc.subject | Pharmaceutical Policy | - |
dc.subject | Drug Accessibility | - |
dc.subject | Right to Health | - |
dc.subject | Patent Law | - |
dc.subject | India | - |
dc.subject | Intellectual Property | - |
dc.title | A Case for Compulsory Licensing for Cancer Drugs in The light of trips and India’s patent Laws | en_US |
dc.type | LL.M Dissertation | en_US |
Appears in Collections: | 2020 - 2021 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
LLM_0220017_CAL.pdf | 794.36 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.